Insider trades
Adjuvant Capital Management, 10% Owner of AN2 Therapeutics ANTX, has filed 0 purchases and 20 sales on the open market. The latest trade was on 24/01/16.
Adjuvant Capital Management
10% Owner
- Company
- AN2 Therapeutics ANTX
- First filing
- 23/08/25
- Trades
- 20 trades
- Buys / sales
- 0 / 20
- 12-month net buying
- No record
- Last trade
- 24/01/16
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ANTX | Open-market sale | 24/01/16 | 24/01/18 | 100,000 sh2 trades | $19.65avg. | $1,965,000 | No record |
ANTX | Open-market sale10b5-1 plan | 23/11/14 | 23/11/16 | 1,810 sh2 trades | $16.15avg. | $29,231.5 | No record |
ANTX | Open-market sale | 23/09/29–23/10/02 | 23/10/03 | 104,773 sh4 trades | $16.27avg. | $1,704,513.32 | No record |
ANTX | Open-market sale | 23/09/27–23/09/28 | 23/09/29 | 9,357 sh4 trades | $16.11avg. | $150,707.63 | No record |
ANTX | Open-market sale | 23/09/13 | 23/09/15 | 400 sh2 trades | $16.00avg. | $6,400 | No record |
ANTX | Open-market sale | 23/09/06–23/09/07 | 23/09/08 | 7,140 sh4 trades | $16.03avg. | $114,484.14 | No record |
ANTX | Open-market sale | 23/08/23 | 23/08/25 | 400 sh2 trades | $16.00avg. | $6,400 | No record |